Autopsy report · NCT04854889

Efficacy and Safety of Low-dose Decitabine in Refractory Aplastic Anemia

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Not achieve the desired effect”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 1 year 4 months before it stopped.
3 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Sponsor type: University, hospital or other
Conditions: Refractory Aplastic Anemia
Interventions: Decitabine
Participants: 3
Sites: 1
Countries: China

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.